Published Date:2022-09-28 Original Link:https://www.onenessbio.com/en/news_detail179_1.htm No 1 Date of announcement 2022/09/28 Time of announcement  19:20:15 Subject Fespixon’s clinical meaningfulness as a macrophage-regulation new drug compared with other DFU treatments has been reviewed and published in Pharmaceutics. To which item it meets paragraph 53 Date of events 2022/09/28 Statement Date of occurrence of the event:2022/09/28 Company name:ONENESS...Read More